Details
| Translated title of the contribution | Cost of illness of acute coronary syndrome in Germany |
|---|---|
| Original language | Multiple languages |
| Pages (from-to) | 122-128 |
| Number of pages | 7 |
| Journal | Kardiologe |
| Volume | 5 |
| Issue number | 2 |
| Early online date | 6 Mar 2011 |
| Publication status | Published - Apr 2011 |
Abstract
Introduction: Acute coronary syndrome (ACS) is an acute disease in patients with coronary heart disease (CHD). The aim of this study is to evaluate the cost of ACS by summarizing reported evidence in order to determine resource use for different treatment situations. Methods: Evaluation of the cost of ACS was based on a structured search in the published literature and official German databases. Results: Approximately 50% (i.e. 3.3 billion euros) of overall direct costs for CHD are incurred by ACS treatment, 60% of which are caused by in-hospital treatments. Men are responsible for 63% of disease-related costs and are more frequently affected than women, with 72% of the total expenditure for ACS allocated to the age group 65-84. Productivity losses based on morbidity and mortality lead to an estimated cost of 2.5 billion euros per year; 127,000 years of employment are lost due to CHD, and half of that is attributable to ACS. Conclusion: Treatment of ACS has the most significant impact of all forms of CHD in terms of cost burden to society and sick funds. In spite of declining death rates due to improved treatment alternatives, the burden of disease and productivity losses based on excess morbidity and mortality are still substantial.
ASJC Scopus subject areas
- Medicine(all)
- Cardiology and Cardiovascular Medicine
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Kardiologe, Vol. 5, No. 2, 04.2011, p. 122-128.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Krankheitskosten des akuten Koronarsyndroms in Deutschland
AU - Damm, K.
AU - Runge, C.
AU - Zeymer, U.
AU - Graf Von Der Schulenburg, J. M.
PY - 2011/4
Y1 - 2011/4
N2 - Introduction: Acute coronary syndrome (ACS) is an acute disease in patients with coronary heart disease (CHD). The aim of this study is to evaluate the cost of ACS by summarizing reported evidence in order to determine resource use for different treatment situations. Methods: Evaluation of the cost of ACS was based on a structured search in the published literature and official German databases. Results: Approximately 50% (i.e. 3.3 billion euros) of overall direct costs for CHD are incurred by ACS treatment, 60% of which are caused by in-hospital treatments. Men are responsible for 63% of disease-related costs and are more frequently affected than women, with 72% of the total expenditure for ACS allocated to the age group 65-84. Productivity losses based on morbidity and mortality lead to an estimated cost of 2.5 billion euros per year; 127,000 years of employment are lost due to CHD, and half of that is attributable to ACS. Conclusion: Treatment of ACS has the most significant impact of all forms of CHD in terms of cost burden to society and sick funds. In spite of declining death rates due to improved treatment alternatives, the burden of disease and productivity losses based on excess morbidity and mortality are still substantial.
AB - Introduction: Acute coronary syndrome (ACS) is an acute disease in patients with coronary heart disease (CHD). The aim of this study is to evaluate the cost of ACS by summarizing reported evidence in order to determine resource use for different treatment situations. Methods: Evaluation of the cost of ACS was based on a structured search in the published literature and official German databases. Results: Approximately 50% (i.e. 3.3 billion euros) of overall direct costs for CHD are incurred by ACS treatment, 60% of which are caused by in-hospital treatments. Men are responsible for 63% of disease-related costs and are more frequently affected than women, with 72% of the total expenditure for ACS allocated to the age group 65-84. Productivity losses based on morbidity and mortality lead to an estimated cost of 2.5 billion euros per year; 127,000 years of employment are lost due to CHD, and half of that is attributable to ACS. Conclusion: Treatment of ACS has the most significant impact of all forms of CHD in terms of cost burden to society and sick funds. In spite of declining death rates due to improved treatment alternatives, the burden of disease and productivity losses based on excess morbidity and mortality are still substantial.
KW - Acute coronary syndrome
KW - Coronary heart disease
KW - Cost of illness
KW - Germany
KW - Myocardial infarction
UR - http://www.scopus.com/inward/record.url?scp=79955987483&partnerID=8YFLogxK
U2 - 10.1007/s12181-011-0328-0
DO - 10.1007/s12181-011-0328-0
M3 - Article
AN - SCOPUS:79955987483
VL - 5
SP - 122
EP - 128
JO - Kardiologe
JF - Kardiologe
SN - 1864-9718
IS - 2
ER -